Cargando…
Renal Effects of Fetal Reprogramming With Pentaerythritol Tetranitrate in Spontaneously Hypertensive Rats
AIMS: Current antihypertensive therapies cannot cure hypertension and a life-long medication is necessary. Maternal treatment may represent a promising strategy for hypertension treatment. We have previously shown that maternal treatment of spontaneously hypertensive rats (SHR) with pentaerythritol...
Autores principales: | Man, Andy W. C., Chen, Min, Wu, Zhixiong, Reifenberg, Gisela, Daiber, Andreas, Münzel, Thomas, Xia, Ning, Li, Huige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201020/ https://www.ncbi.nlm.nih.gov/pubmed/32410988 http://dx.doi.org/10.3389/fphar.2020.00454 |
Ejemplares similares
-
Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia
por: Man, Andy W. C., et al.
Publicado: (2020) -
Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension
por: Steven, Sebastian, et al.
Publicado: (2017) -
Vascular Dysfunction in Experimental Diabetes Is Improved by Pentaerithrityl Tetranitrate but Not Isosorbide-5-Mononitrate Therapy
por: Schuhmacher, Swenja, et al.
Publicado: (2011) -
Analysis of Chemical Reaction Process after Pentaerythritol
Tetranitrate Hot Spot Ignition
por: Zhang, Yaping, et al.
Publicado: (2020) -
Chemical Evaluation and Performance Characterization
of Pentaerythritol Tetranitrate (PETN) under Melt Conditions
por: Manner, Virginia W., et al.
Publicado: (2022)